Results 251 to 260 of about 1,006,225 (339)

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

, 2010
Dario Baratti, Marco Vaira, Shigeki Kusamura, Silvia D’Amico, Maria Rosaria Balestra, Tommaso Cioppa, Elvira Mingrone, Michele De Simone, Marcello Deraco   +8 more
openalex   +2 more sources

Brazilian Society of Surgical Oncology: Guidelines for the Lymphadenectomy in Colorectal Cancer

Journal of Surgical Oncology, EarlyView.
ABSTRACT The BSSO developed the present guidelines to provide recommendations based on current scientific evidence that is focused on the main topics related to the daily surgical practice of lymphadenectomy in colorectal cancer. Between October 2024 and February 2025, nine experts met to develop the guidelines for the lymphadenectomy in colorectal ...
Jorge Mali, Marcus Valadão, Rodrigo Otavio Araujo, Carlos Bernardo Cola, Carlos Augusto Rodrigues Veo, Heládio Feitosa e Castro Neto, Alexandre Ferreira Oliveira, Reitan Ribeiro, Rodrigo Nascimento Pinheiro   +8 more
wiley   +1 more source

Safety of BromAc^® with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study. [PDF]

Am J Cancer Res
Mekkawy AH, Breakeit M, Rahman MK, Pillai K, Solanki A, Octavia F, Badar S, Akhter J, Valle SJ, Morris DL.   +9 more
europepmc   +1 more source

Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer

, 2010
Bernardino Rampone
openalex   +1 more source

Evaluating Respiratory Complications Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Subphrenic Peritonectomy Versus Full Thickness Diaphragm Resection

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Patients with diaphragm tumor deposits undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) require subphrenic peritonectomy (SPP) or full‐thickness diaphragm resection (FTR) to achieve complete cytoreduction.
Claire Liu, Kadhim Taqi, Marina Parapini, Andrea J. MacNeill, Trevor D. Hamilton   +4 more
wiley   +1 more source

Evaluating the Impact of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Interval and Secondary Debulking in Ovarian Cancer: A Systematic Review. [PDF]

Cancers (Basel)
Tsolakidis D, Kyziridis D, Panoskaltsis T, Kalakonas A, Theodoulidis V, Chatzistamatiou K, Zouzoulas D, Tentes AA.   +7 more
europepmc   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

Small, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai, Dhwani Rana, Mitali Patel, Neha Bajwa, Rajendra Prasad, Lalitkumar K. Vora   +5 more
wiley   +1 more source

Hyperthermic intraperitoneal chemotherapy in colorectal cancer. [PDF]

BJS Open
Rau B, Gül-Klein S.
europepmc   +2 more sources

Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Can We Do Better? [PDF]

J Surg Oncol
Alberto V ME, Zuluaga D, Winter A, Pratschke J, Rau B, Gül S.   +5 more
europepmc   +1 more source

Understanding of endo/lysosomal escape of nanomaterials in biomedical application

Smart Molecules, EarlyView.
This review summarized mainstream mechanisms of endo/lysosomal escape and design strategies of endo/lysosomal escapable nanoparticles in view of surface charge, polarity & hydrophobicity, particle morphology, and lysosomal escape agents. The utilization of endo/lysosomal escapable nanoparticles for vaccine delivery and genetic engineering are ...
Xin Wang, Haoyu Li, Chen Chen, Zhihui Liang   +3 more
wiley   +1 more source